METASTATIC PARAGANGLIOMA
Clinical trials for METASTATIC PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for METASTATIC PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for rare and Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pembrolizumab (Keytruda) in 157 people with rare cancers that have spread or cannot be removed. The drug helps the immune system fight cancer by blocking a protein that tumors use to hide. The main goal is to see if the drug can stop the cancer from…
Matched conditions: METASTATIC PARAGANGLIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New combo therapy shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide can better control advanced pheochromocytoma and paraganglioma, rare neuroendocrine tumors that have spread or cannot be removed surgically. About 46 adults with these cancers will be randomly assi…
Matched conditions: METASTATIC PARAGANGLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC